Kensey Nash Corp (KNSY)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Employees:
735 PENNSYLVANIA DRIVE, EXTON, PA 19341
6105947156

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

Data derived from most recent annual or quarterly report
Market Cap 328.064 Million Shares Outstanding8.53 Million Avg 30-day Volume 117.994 Thousand
P/E Ratio0.0 Dividend Yield0.862 EPS0.34
Price to Revenue0.0 Debt to Equity0.3018 EBITDA0
Price to Book Value2.6474 Operating Margin0.0 Enterprise Value243.372 Million
Current Ratio2.243 EPS Growth0 Quick Ratio1.442
1 Yr BETA 0.7191 52-week High/Low 0.0 / Profit Margin0.0
Operating Cash Flow Growth0.0 Altman Z-Score3.3543 Free Cash Flow to Firm 0
View SEC Filings from KNSY instead.

View recent insider trading info

Funds Holding KNSY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding KNSY

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

NASH JOHN E VP NEW TECHNOLOGIES

  • Officer
0 2012-06-22 0

EVARTS C MCCOLLISTER

  • Director
No longer subject to file 2012-06-22 0

MOREL DONALD E JR

  • Director
No longer subject to file 2012-06-22 0

MAUPAY WALTER R JR

  • Director
No longer subject to file 2012-06-22 0

BOBB ROBERT J

  • Director
No longer subject to file 2012-06-22 0

EVANS DOUGLAS G COO

  • Officer
  • Director
0 2012-06-22 0

KAUFMANN JOSEPH W PRESIDENT, CEO AND SECRETARY

  • Officer
  • Director
0 2012-06-22 0

ROYAL DSM N.V.

  • 10% Owner
15,061,177 2012-06-22 0

CELANO MICHAEL CHIEF FINANCIAL OFFICER

  • Officer
0 2012-06-22 0

RAUTH JAMES T VP OF OPERATIONS

  • Officer
0 2012-06-22 0

DEWITT TODD M VP OF BIOMATERIALS

  • Officer
0 2012-06-22 0

EARNHARDT LISA

  • Director
No longer subject to file 2012-06-22 0

CHEFITZ HAROLD N

  • Director
18,833 2010-10-27 0

KRONENGOLD RUSSELL T VP OF BIOMATERIALS RESEARCH

  • Officer
1,256 2009-09-22 0

C4S & CO LLC

COHEN PETER A

STARK MORGAN B

STRAUSS THOMAS W

SOLOMON JEFFREY M

  • Director
No longer subject to file 2009-02-03 0

RAMIUS LLC

STARBOARD VALUE & OPPORTUNITY MASTER FUND LTD

PARCHE, LLC

RCG STARBOARD ADVISORS, LLC

RCG ENTERPRISE LTD

RAMIUS ADVISORS LLC

  • Director
No longer subject to file 2009-02-03 0

LEE STEVEN J

  • Director
17,905 2008-12-10 0

SMITH JEFFREY C

  • Director
10,406 2008-12-10 0

ANQUILLARE CEASAR

  • Director
10,406 2008-12-10 0

LAKE RYAN DAVID DIRECTOR OF FINANCE (SEE NOTE)

  • Officer
0 2008-11-15 0

RAMIUS LLC

C4S & CO LLC

COHEN PETER A

STARK MORGAN B

STRAUSS THOMAS W

SOLOMON JEFFREY M

STARBOARD VALUE & OPPORTUNITY MASTER FUND LTD

PARCHE, LLC

RCG STARBOARD ADVISORS, LLC

RCG ENTERPRISE LTD

  • 10% Owner
  • SEE EXPLANATION OF RESPONSES
4,133,835 2008-10-06 0

DICICCO WENDY F CFO

  • Officer
11,353 2008-09-22 0

CAROUGE M KEVIN VP BIOMATERIALS MARKET DEVELOP

  • Officer
0 2008-09-22 0

FELD PETER A

  • SEE EXPLANATION OF RESPONSES
0 2007-10-10 0

ROSENBERG KIM D

  • Director
7,499 2007-10-05 0

RAMIUS CAPITAL GROUP LLC

C4S & CO LLC

COHEN PETER A

STARK MORGAN B

STRAUSS THOMAS W

SOLOMON JEFFREY M

STARBOARD VALUE & OPPORTUNITY MASTER FUND LTD

PARCHE, LLC

RCG STARBOARD ADVISORS, LLC

  • 10% Owner
  • SEE EXPLANATION OF RESPONSES
2,485,740 2007-08-29 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments